Fresenius Medical Care AG (FMS) EBIT (2009 - 2025)

Fresenius Medical Care AG's EBIT history runs 17 years deep, the most recent figure standing at $2.1 billion for Q4 2025.

• In Q4 2025, EBIT rose 42.94% year-over-year to $2.1 billion; the TTM figure through Dec 2025 stood at $3.5 billion (up 29.11% YoY), while the FY2025 annual figure was $2.1 billion, up 42.97% from the prior year.
• EBIT was $2.1 billion for Q4 2025 at Fresenius Medical Care AG, up from $557.1 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $2.1 billion in Q4 2025 to a low of $267.2 million in Q1 2024.
• Historically, EBIT has averaged $764.9 million across 5 years, with a median of $494.6 million in 2024.
• The sharpest annual moves came in 2022 and 2024: EBIT tumbled 31.69% in 2022, then surged 44.07% in 2024.
• A 5-year view of EBIT shows it stood at $2.1 billion in 2021, then dropped by 27.21% to $1.5 billion in 2022, then declined by 4.47% to $1.5 billion in 2023, then gained by 0.98% to $1.5 billion in 2024, then jumped by 42.94% to $2.1 billion in 2025.
• The last three EBIT figures came in at $2.1 billion (Q4 2025), $557.1 million (Q3 2025), and $481.1 million (Q2 2025), per Business Quant data.